Tuesday, December 24, 2024
HomeIndustriesHealthcare

Healthcare

Renexxion Ireland Announces Issuance of a New US Patent covering Naronapride, a Clinical Stage Potential Best-in-Class Prokinetic Agent for Gastrointestinal disorders

Renexxion Ireland Ltd., a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need gastrointestinal ("GI") disorders, announced the issuance...

Merck and Ridgeback’s Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) has granted...

Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services

Labcorp, a leading global life sciences company, announced that it has entered into a definitive agreement to acquire Personal Genome Diagnostics Inc. (PGDx), a...

Biondvax Collaborates With Max Planck Institute and University Medical Center Göttingen for COVID-19 Therapeutics

BiondVax Pharmaceuticals Ltd. , a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and...

Viseven joins Veeva’s new Digital Factory Accelerator Program (DFAP)

Viseven Group announced that it has joined Veeva Systems' new Digital Factory Accelerator Program (DFAP). The program helps content partners work closely with pharmaceutical...
0FansLike
0FollowersFollow
spot_img

Hot Topics